Search Results - "Mahmut TÖBÜ"

Refine Results
  1. 1

    Real-Life Experience with Pomalidomide plus Dexamethasone in Patients with Multiple Myeloma: A Single Center Retrospective Study by Betül Kübra TÜZÜN, Zühal DEMİRCİ, Gülçin ÇELEBİ, Ajda GÜNEŞ, Derya DEMİR, Nur SOYER, Filiz VURAL, Mahmut TÖBÜ, Fahri ŞAHİN, Güray SAYDAM

    Published in Hematology, Transfusion and Cell Therapy (01-05-2024)
    “…Objective: Multiple myeloma (MM) is a heterogeneous disease with the uncontrolled clonal proliferation of plasma cells, accounting for approximately 10% of all…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Does immunohistochemical staining predict mobilization success in multiple myeloma patients? by Karadag, Fatma Keklik, Aysin, Murat, Soyer, Nur, Güneş, Ajda, Bozer, Denis, Demir, Derya, Arslan, Aysenur, Sahin, Fahri, Töbü, Mahmut, Saydam, Guray, Vural, Filiz

    Published in Transfusion and apheresis science (01-12-2024)
    “…So many risk factors for mobilization failure have been described so far. We aimed to identify the risk factors and search the possible effects of bone marrow…”
    Get full text
    Journal Article
  4. 4

    A complex t(15;22;17)(q22;q11.2;q21) variant of APL by Ak, Bilgesu, Güngör, Özge, Karaca, Emin, Durmaz, Burak, Bozer, Denis S., Töbü, Mahmut, Akın, Haluk

    Published in Cancer genetics (01-08-2024)
    “…The present study described an extremely rare case of acute promyelocytic leukemia (APL) characterized by a complex three‑way (15;22;17)(q22;q11.2;q21)…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Report on Three Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm by Bülbül, Hale, Özsan, Nazan, Hekimgil, Mine, Saydam, Güray, Töbü, Mahmut

    Published in Turkish journal of haematology (2018)
    “…To the Editor, Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, clinically aggressive tumor that was classified as a distinct entity among…”
    Get full text
    Journal Article
  8. 8

    CT-230 Evaluation of BK Polyomavirus Infection Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation (allo-SCT): A Single Center Experience by Gezici, Barış, Soyer, Nur Akad, Güneş, Ajda Ersoy, Saydam, Güray, Töbü, Mahmut, Şahin, Fahri, Vural, Filiz

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…Hemorrhagic cystitis (HC) is a clinical entity that mostly occurs after allo-SCT and reduces the quality of life of patients, prolongs hospitalization and…”
    Get full text
    Journal Article
  9. 9

    CT-232 Evaluation of the Effects of Cytomegalovirus and BK Polyomavirus Infections on Overall Survival Following Allogeneic Stem Cell Transplantation: A Single Center Experience by Gezici, Barış, Soyer, Nur Akad, Güneş, Ajda Ersoy, Saydam, Güray, Töbü, Mahmut, Şahin, Fahri, Vural, Filiz

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…This study aims to investigate the impact of cytomegalovirus (CMV) infection, CMV disease, and development of BK polyomavirus-associated hemorrhagic cystitis…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience by Gezici, Barış, Güneş, Ajda Ersoy, Soyer, Nur Akad, Saydam, Güray, Töbü, Mahmut, Şahin, Fahri, Vural, Filiz

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…The objective of this retrospective, observational study was to investigate the frequency of cytomegalovirus (CMV) infection and CMV disease in adult patients…”
    Get full text
    Journal Article
  14. 14

    Progressive Transformation of Germinal Centers: Single Center Experience of 33 Turkish Patients by Özkan, Melda Cömert, Specialist, Özsan, Nazan, Associate Professor, Hekimgil, Mine, Professor, Saydam, Güray, Professor, Töbü, Mahmut, Professor

    Published in Clinical lymphoma, myeloma and leukemia (01-08-2016)
    “…Abstract Background Progressive transformation of germinal centers (PTGC) is a benign disease of the lymph nodes which is rarely associated with Hodgkin…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    CT-129 A Rare, Challenging Disease: Langerhans Cell Histiocytosis, a Single-Center Experience by Tüzün, Betül Kübra, Davulcu, Eren Aslan, Güneş, Ajda, Demir, Derya, Soyer, Nur, Töbü, Mahmut, Vural, Filiz, Kamer, Serra, Bayraktaroğlu, Selen, Şahin, Fahri, Saydam, Güray

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…The objective of this retrospective study was to analyze the diagnostic procedures, clinical course, and treatment outcomes of patients with Langerhans cell…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience by Uysal, Ayşe, Akad Soyer, Nur, Özkan, Melda, Şahin, Fahri, Vural, Filiz, Töbü, Mahmut, Tombuloğlu, Murat, Saydam, Güray

    Published in Turkish journal of medical sciences (23-02-2018)
    “…Background/aim: Carfilzomib (CFZ) is a new-generation proteasome inhibitor with significant activity in relapsed or refractory multiple myeloma (R/R-MM). We…”
    Get full text
    Journal Article
  20. 20